A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission
Volunteers
Health Professionals
What is the purpose of this trial?
This randomized phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative mantle cell lymphoma in first complete remission. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant helps kill any cancer cells that are in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy is then given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. Giving rituximab with or without stem cell transplant may work better in treating patients with mantle cell lymphoma.
- Trial withEastern Coop Onc Group-American College Radiology Imaging Netwk(ECOG-ACRIN)
- Ages18 years - 70 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Agatha Hecht
- Alfredo Axtmayer
- Alison Johnson
- Ashita Talsania, MRCP, MBBS
- Elan Gorshein, DO, JD, MPH
- Ethan Kohn
- Francine Foss, MD
- Jade Vanacore
- James Vredenburgh, MD
- Jean Vollmer
- Karishma Mehra, MBBS
- Katherine Harvey, MD, MPH
- Kayla Martello
- Madeline Santiago
- Osarugue Otasowie
- Pawan Karanam, MD
- Sarah Thomen, APRN
- Scott Huntington, MD, MPH, MSc
- Shalin Kothari, MD
- Stuart Seropian, MD
- Sudhanshu Mulay, MD
- Syed Ali
- Syed Bilgrami, MBBS
- Tarsheen Sethi, MD, MSc
- Vidya Kesavan
- Zia Rahman, MD
- Last Updated09/19/2024
- Study HIC#2000023593